March 2017

dtra-ciproflaxin-liposomes

Leveraging approved drugs

The Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) is working to develop more effective broad-spectrum antibacterials to overcome resistance by developing innovative formulations of approved antibiotics and increasing their efficacy through…